Logo image of ZAL.DE

ZALANDO SE (ZAL.DE) Stock Fundamental Analysis

FRA:ZAL - Deutsche Boerse Ag - DE000ZAL1111 - Common Stock - Currency: EUR

25.62  +0.66 (+2.64%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ZAL. ZAL was compared to 51 industry peers in the Specialty Retail industry. ZAL scores excellent on profitability, but there are some minor concerns on its financial health. ZAL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ZAL was profitable.
ZAL had a positive operating cash flow in the past year.
ZAL had positive earnings in each of the past 5 years.
ZAL had a positive operating cash flow in each of the past 5 years.
ZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

With a decent Return On Assets value of 3.33%, ZAL is doing good in the industry, outperforming 68.63% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.03%, ZAL is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
ZAL has a better Return On Invested Capital (6.33%) than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ZAL is significantly below the industry average of 8.81%.
The last Return On Invested Capital (6.33%) for ZAL is above the 3 year average (3.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.33%
ROE 10.03%
ROIC 6.33%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ZAL.DE Yearly ROA, ROE, ROICZAL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 2.51%, ZAL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of ZAL has grown nicely.
ZAL's Operating Margin of 3.83% is fine compared to the rest of the industry. ZAL outperforms 62.75% of its industry peers.
ZAL's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 40.85%, ZAL is in line with its industry, outperforming 52.94% of the companies in the same industry.
In the last couple of years the Gross Margin of ZAL has remained more or less at the same level.
Industry RankSector Rank
OM 3.83%
PM (TTM) 2.51%
GM 40.85%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
ZAL.DE Yearly Profit, Operating, Gross MarginsZAL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZAL is still creating some value.
Compared to 1 year ago, ZAL has less shares outstanding
Compared to 5 years ago, ZAL has more shares outstanding
The debt/assets ratio for ZAL has been reduced compared to a year ago.
ZAL.DE Yearly Shares OutstandingZAL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ZAL.DE Yearly Total Debt VS Total AssetsZAL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.86 indicates that ZAL is not a great score, but indicates only limited risk for bankruptcy at the moment.
ZAL has a Altman-Z score of 2.86. This is in the better half of the industry: ZAL outperforms 76.47% of its industry peers.
ZAL has a debt to FCF ratio of 3.96. This is a good value and a sign of high solvency as ZAL would need 3.96 years to pay back of all of its debts.
ZAL has a better Debt to FCF ratio (3.96) than 62.75% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that ZAL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.43, ZAL is in line with its industry, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 3.96
Altman-Z 2.86
ROIC/WACC1.03
WACC6.14%
ZAL.DE Yearly LT Debt VS Equity VS FCFZAL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

ZAL has a Current Ratio of 1.36. This is a normal value and indicates that ZAL is financially healthy and should not expect problems in meeting its short term obligations.
ZAL has a Current ratio of 1.36. This is in the better half of the industry: ZAL outperforms 62.75% of its industry peers.
ZAL has a Quick Ratio of 1.36. This is a bad value and indicates that ZAL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.89, ZAL is doing good in the industry, outperforming 72.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.89
ZAL.DE Yearly Current Assets VS Current LiabilitesZAL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

ZAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 136.36%, which is quite impressive.
ZAL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.33% yearly.
ZAL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.14%.
The Revenue has been growing by 10.28% on average over the past years. This is quite good.
EPS 1Y (TTM)136.36%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%233.33%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%7.95%

3.2 Future

ZAL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.46% yearly.
The Revenue is expected to grow by 7.36% on average over the next years.
EPS Next Y23.95%
EPS Next 2Y24.77%
EPS Next 3Y24.16%
EPS Next 5Y24.46%
Revenue Next Year6.58%
Revenue Next 2Y6.37%
Revenue Next 3Y6.13%
Revenue Next 5Y7.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZAL.DE Yearly Revenue VS EstimatesZAL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
ZAL.DE Yearly EPS VS EstimatesZAL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.63, which indicates a rather expensive current valuation of ZAL.
62.75% of the companies in the same industry are more expensive than ZAL, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ZAL to the average of the S&P500 Index (26.82), we can say ZAL is valued inline with the index average.
The Price/Forward Earnings ratio is 16.97, which indicates a correct valuation of ZAL.
Based on the Price/Forward Earnings ratio, ZAL is valued a bit cheaper than the industry average as 62.75% of the companies are valued more expensively.
ZAL is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.63
Fwd PE 16.97
ZAL.DE Price Earnings VS Forward Price EarningsZAL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

68.63% of the companies in the same industry are more expensive than ZAL, based on the Enterprise Value to EBITDA ratio.
ZAL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 15.66
EV/EBITDA 6.91
ZAL.DE Per share dataZAL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ZAL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ZAL may justify a higher PE ratio.
A more expensive valuation may be justified as ZAL's earnings are expected to grow with 24.16% in the coming years.
PEG (NY)1.03
PEG (5Y)1.06
EPS Next 2Y24.77%
EPS Next 3Y24.16%

0

5. Dividend

5.1 Amount

No dividends for ZAL!.
Industry RankSector Rank
Dividend Yield N/A

ZALANDO SE

FRA:ZAL (8/4/2025, 3:41:32 PM)

25.62

+0.66 (+2.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners62.55%
Inst Owner ChangeN/A
Ins Owners10.07%
Ins Owner ChangeN/A
Market Cap6.77B
Analysts77.58
Price Target39.12 (52.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)454.43%
Min EPS beat(2)16.78%
Max EPS beat(2)892.08%
EPS beat(4)4
Avg EPS beat(4)243.23%
Min EPS beat(4)2.21%
Max EPS beat(4)892.08%
EPS beat(8)4
Avg EPS beat(8)68.14%
EPS beat(12)7
Avg EPS beat(12)1.44%
EPS beat(16)7
Avg EPS beat(16)-20.71%
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.99%
Max Revenue beat(2)1.19%
Revenue beat(4)3
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-1.22%
Max Revenue beat(4)1.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.58%
Revenue beat(12)4
Avg Revenue beat(12)-0.66%
Revenue beat(16)6
Avg Revenue beat(16)-0.74%
PT rev (1m)-1.27%
PT rev (3m)-1.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.41%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)4.15%
Revenue NQ rev (3m)4.3%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE 24.63
Fwd PE 16.97
P/S 0.63
P/FCF 15.66
P/OCF 11.04
P/B 2.52
P/tB 2.96
EV/EBITDA 6.91
EPS(TTM)1.04
EY4.06%
EPS(NY)1.51
Fwd EY5.89%
FCF(TTM)1.64
FCFY6.39%
OCF(TTM)2.32
OCFY9.06%
SpS40.7
BVpS10.18
TBVpS8.66
PEG (NY)1.03
PEG (5Y)1.06
Profitability
Industry RankSector Rank
ROA 3.33%
ROE 10.03%
ROCE 10.33%
ROIC 6.33%
ROICexc 16.78%
ROICexgc 22.93%
OM 3.83%
PM (TTM) 2.51%
GM 40.85%
FCFM 4.02%
ROA(3y)1.48%
ROA(5y)2.26%
ROE(3y)4.56%
ROE(5y)6.95%
ROIC(3y)3.34%
ROIC(5y)4.59%
ROICexc(3y)9.52%
ROICexc(5y)14.27%
ROICexgc(3y)13.4%
ROICexgc(5y)19.23%
ROCE(3y)5.45%
ROCE(5y)7.5%
ROICexcg growth 3Y8.96%
ROICexcg growth 5Y22.36%
ROICexc growth 3Y2.72%
ROICexc growth 5Y17.49%
OM growth 3Y-2.26%
OM growth 5Y7.72%
PM growth 3Y1.6%
PM growth 5Y9.08%
GM growth 3Y-0.88%
GM growth 5Y-0.89%
F-Score8
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 3.96
Debt/EBITDA 1.52
Cap/Depr 51.03%
Cap/Sales 1.68%
Interest Coverage 250
Cash Conversion 79.99%
Profit Quality 160.17%
Current Ratio 1.36
Quick Ratio 0.89
Altman-Z 2.86
F-Score8
WACC6.14%
ROIC/WACC1.03
Cap/Depr(3y)86.74%
Cap/Depr(5y)104.05%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.86%
Profit Quality(3y)549.88%
Profit Quality(5y)378.62%
High Growth Momentum
Growth
EPS 1Y (TTM)136.36%
EPS 3Y2.91%
EPS 5Y23.33%
EPS Q2Q%233.33%
EPS Next Y23.95%
EPS Next 2Y24.77%
EPS Next 3Y24.16%
EPS Next 5Y24.46%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y0.7%
Revenue growth 5Y10.28%
Sales Q2Q%7.95%
Revenue Next Year6.58%
Revenue Next 2Y6.37%
Revenue Next 3Y6.13%
Revenue Next 5Y7.36%
EBIT growth 1Y89.26%
EBIT growth 3Y-1.58%
EBIT growth 5Y18.79%
EBIT Next Year114.38%
EBIT Next 3Y39.75%
EBIT Next 5Y30.53%
FCF growth 1Y0.14%
FCF growth 3Y16.44%
FCF growth 5Y84.9%
OCF growth 1Y-18.75%
OCF growth 3Y2.01%
OCF growth 5Y14.86%